Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Carcinoma, Non-Small-Cell Lung × Defecation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 323 Pemetrexed 266 pembrolizumab 262 Cisplatin 215 Paclitaxel 204 Docetaxel 177 Gemcitabine 113 Nivolumab 106 Erlotinib Hydrochloride 102 Bevacizumab 76 osimertinib 68 atezolizumab 54 durvalumab 53 Cetuximab 50 130-nm albumin-bound paclitaxel 48 Gefitinib 47 Ipilimumab 35 Afatinib 34 Drug Therapy 31 Cyclophosphamide 29 Albumin-Bound Paclitaxel 27 Crizotinib 26 Vinorelbine 25 tislelizumab 24 cemiplimab 23 icotinib 21 avelumab 21 Radiotherapy 21 capmatinib 19 Oxaliplatin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05736029 2023-02-21

PROPHETIC

OncoHost Ltd.

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡